Clinical trial
A Prospective Study of High Dose Radiotherapy for Palliation: Hi-D
NCT07291895 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of High Dose Radiotherapy for Palliation: Hi-D
- Lead sponsor
- British Columbia Cancer Agency
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 1, 2027
- Completion date
- August 31, 2030
- Enrollment
- 21 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastases, palliative radiotherapy